BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33832113)

  • 1. Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.
    Birlutiu V; Birlutiu RM; Iancu GM
    Medicine (Baltimore); 2021 Apr; 100(14):e25352. PubMed ID: 33832113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pityriasis Rosea after COVID-19 Infection.
    Prtajin M; Ljubojević Hadžavdić S
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
    Drago F; Broccolo F; Ciccarese G
    Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine.
    Cohen OG; Clark AK; Milbar H; Tarlow M
    Hum Vaccin Immunother; 2021 Nov; 17(11):4097-4098. PubMed ID: 34435935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID-19.
    Martín Enguix D; Salazar Nievas MDC; Martín Romero DT
    Med Clin (Barc); 2020 Sep; 155(6):273. PubMed ID: 32654832
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
    Dursun R; Temiz SA
    Dermatol Ther; 2020 Jul; 33(4):e13730. PubMed ID: 32475003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
    Borgia F; Li Pomi F; Alessandrello C; Vaccaro M; Pioggia G; Gangemi S
    J Dermatol; 2022 Oct; 49(10):948-956. PubMed ID: 35675487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.
    Wong N; Cascardo CA; Mansour M; Qian V; Potts GA
    Cureus; 2023 May; 15(5):e38772. PubMed ID: 37303403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
    Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S
    Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational Pityriasis Rosea: Suggestions for Approaching Affected Pregnant Women.
    Monastirli A; Pasmatzi E; Badavanis G; Tsambaos D
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):312-313. PubMed ID: 28128088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesicular palmoplantar pityriasis rosea.
    Singh V; Sharma M; Narang T; Madan M
    Skinmed; 2012; 10(2):116-8. PubMed ID: 22545332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature.
    Veraldi S; Boneschi V; Cusini M; Maronese CA
    Dermatol Reports; 2023 Mar; 15(1):9503. PubMed ID: 37063394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pityriasis rosea following SARS-CoV-2 vaccination: A case series.
    Temiz SA; Abdelmaksoud A; Dursun R; Durmaz K; Sadoughifar R; Hasan A
    J Cosmet Dermatol; 2021 Oct; 20(10):3080-3084. PubMed ID: 34363731
    [No Abstract]   [Full Text] [Related]  

  • 14. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review.
    Pedrazini MC; da Silva MH
    Dermatol Ther; 2021 Nov; 34(6):e15129. PubMed ID: 34533265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapsing Pityriasis Rosea With HHV-7 Reactivation in an 11-Year-Old Girl.
    Engelmann I; Ogiez J; Ogiez L; Alidjinou EK; Lazrek M; Dewilde A; Hober D
    Pediatrics; 2018 May; 141(5):. PubMed ID: 29674359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood pityriasis rosea.
    Gündüz O; Ersoy-Evans S; Karaduman A
    Pediatr Dermatol; 2009; 26(6):750-1. PubMed ID: 20199459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pityriasis rosea like drug rash - a need to identify the disease in childhood.
    Panda M; Patro N; Jena M; Dash M; Mishra S
    J Clin Diagn Res; 2014 Aug; 8(8):YD01-2. PubMed ID: 25302254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pityriasis rosea-like eruption revealing COVID-19.
    Veraldi S; Romagnuolo M; Benzecry V
    Australas J Dermatol; 2021 May; 62(2):e333-e334. PubMed ID: 33216971
    [No Abstract]   [Full Text] [Related]  

  • 19. Pityriasis Rosea: An Updated Review.
    Leung AKC; Lam JM; Leong KF; Hon KL
    Curr Pediatr Rev; 2021; 17(3):201-211. PubMed ID: 32964824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular study of recent virus and its relationship to Pityriasis rosea.
    Kawen AA
    J Popul Ther Clin Pharmacol; 2022; 29(1):e109-e115. PubMed ID: 35686902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.